CIK 0001280263
- Large accelerated filer
AMBARELLA INC
Sign in to watch- Ticker
- AMBA
- Exchange
- Nasdaq
- Industry
- Semiconductors & Related Devices
- FY end
- Jan 31
- Entity type
- Operating
- EIN
- 980459628
- Phone
- +1 408-734-8888
- Business address
- 3001 TASMAN DRIVE, SANTA CLARA, CA, 95054
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,060,264
- in 6 filings, $145K under 10b5-1 plans
Net −$1,060,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-16 | Wang Feng-Ming CEO | Exercise or conversion · Restricted Stock Units | −5,250 | 10,500 | ||
| 2018-03-16 | VERHALEN ANDREW W Director | Exercise or conversion | +1,232 | 55,361 | ||
| 2018-03-16 | VERHALEN ANDREW W Director | Exercise or conversion · Restricted Stock Units | −1,232 | 2,463 | ||
| 2018-03-12 | PAISLEY CHRISTOPHER B Director | Exercise or conversion | +1,000 | $6.00 | $6K | 15,302 |
| 2018-03-12 | PAISLEY CHRISTOPHER B Director | Sale | −1,000 | $54.87 | $55K | 14,302 |
| 2018-03-12 | PAISLEY CHRISTOPHER B Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,000 | 10,667 | ||
| 2018-02-26 | Laplante George Chief Financial Officer | Grant or award · Restricted Stock Units | +9,019 | 9,019 | ||
| 2018-02-26 | Day Christopher VP, Marketing | Grant or award · Restricted Stock Units | +3,758 | 3,758 | ||
| 2018-02-26 | Chen Yun-Lung VP, Business Development | Grant or award · Restricted Stock Units | +3,984 | 3,984 | ||
| 2018-02-26 | Kohn Leslie Chief Technology Officer | Grant or award · Restricted Stock Units | +11,199 | 11,199 | ||
| 2018-02-26 | Wang Feng-Ming CEO | Grant or award · Restricted Stock Units | +39,437 | 39,437 | ||
| 2017-12-29 | Chen Yun-Lung VP, Business Development | Sale | −4,435 | $59.80 | $265K | 10,275 |
| 2017-12-18 | Laplante George Chief Financial Officer | Exercise or conversion | +4,947 | 102,941 | ||
| 2017-12-18 | Laplante George Chief Financial Officer | Sale | −4,202 | $57.69 | $242K | 98,739 |
| 2017-12-18 | Laplante George Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,104 | 14,732 | ||
| 2017-12-18 | Laplante George Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,843 | 8,532 | ||
| 2017-12-18 | Day Christopher VP, Marketing | Exercise or conversion | +1,839 | 22,216 | ||
| 2017-12-18 | Day Christopher VP, Marketing | Sale | −1,111 | $57.69 | $64K | 21,105 |
| 2017-12-18 | Day Christopher VP, Marketing | Exercise or conversion · Restricted Stock Units | −877 | 6,139 | ||
| 2017-12-18 | Day Christopher VP, Marketing | Exercise or conversion · Restricted Stock Units | −962 | 2,888 |
Page 78 of 85 · 1,686 trades